Bradley James Petek, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Athletes | 24 | 2024 | 1093 | 3.370 |
Why?
|
Sports | 6 | 2024 | 688 | 2.970 |
Why?
|
Oxygen Consumption | 5 | 2023 | 1869 | 1.810 |
Why?
|
Exercise Test | 4 | 2023 | 2074 | 1.590 |
Why?
|
Death, Sudden, Cardiac | 10 | 2024 | 1542 | 1.200 |
Why?
|
Heart Diseases | 7 | 2023 | 2789 | 1.080 |
Why?
|
Cardiomyopathies | 6 | 2023 | 1911 | 0.970 |
Why?
|
Tetrahydroisoquinolines | 2 | 2015 | 90 | 0.970 |
Why?
|
Electrocardiography | 11 | 2024 | 6441 | 0.960 |
Why?
|
Sarcoidosis | 5 | 2020 | 506 | 0.890 |
Why?
|
Echocardiography | 5 | 2022 | 5096 | 0.840 |
Why?
|
Mass Screening | 7 | 2024 | 5251 | 0.810 |
Why?
|
Pulmonary Ventilation | 1 | 2023 | 374 | 0.760 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2015 | 627 | 0.740 |
Why?
|
Cardiovascular System | 2 | 2023 | 828 | 0.650 |
Why?
|
Coronary Vessel Anomalies | 1 | 2022 | 314 | 0.640 |
Why?
|
Bronchoalveolar Lavage | 1 | 2018 | 120 | 0.640 |
Why?
|
Coronary Occlusion | 1 | 2021 | 304 | 0.640 |
Why?
|
Medical Futility | 1 | 2019 | 127 | 0.620 |
Why?
|
Out-of-Hospital Cardiac Arrest | 2 | 2021 | 339 | 0.610 |
Why?
|
Myocarditis | 2 | 2022 | 768 | 0.600 |
Why?
|
Heart Arrest | 2 | 2019 | 1470 | 0.590 |
Why?
|
Cardiovascular Agents | 1 | 2023 | 850 | 0.570 |
Why?
|
Cardiology | 2 | 2020 | 1668 | 0.560 |
Why?
|
Exercise | 5 | 2023 | 5611 | 0.530 |
Why?
|
Aorta | 1 | 2022 | 2062 | 0.490 |
Why?
|
Dioxoles | 1 | 2015 | 104 | 0.490 |
Why?
|
Athletic Injuries | 1 | 2023 | 1154 | 0.460 |
Why?
|
Physical Examination | 3 | 2022 | 1235 | 0.380 |
Why?
|
Decision Support Techniques | 1 | 2019 | 1956 | 0.330 |
Why?
|
Registries | 7 | 2023 | 8090 | 0.320 |
Why?
|
Biopsy | 1 | 2018 | 6750 | 0.280 |
Why?
|
Humans | 44 | 2024 | 743811 | 0.270 |
Why?
|
Ultrasonography | 1 | 2018 | 5986 | 0.260 |
Why?
|
Coronary Artery Disease | 2 | 2021 | 6485 | 0.250 |
Why?
|
Atrial Fibrillation | 1 | 2022 | 5033 | 0.230 |
Why?
|
Sarcoma | 1 | 2015 | 1898 | 0.230 |
Why?
|
Medical Oncology | 1 | 2015 | 2267 | 0.220 |
Why?
|
Acute Kidney Injury | 1 | 2015 | 1968 | 0.220 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7270 | 0.220 |
Why?
|
Contrast Media | 1 | 2015 | 5301 | 0.210 |
Why?
|
Tomography, X-Ray Computed | 5 | 2021 | 20121 | 0.210 |
Why?
|
Hypertension | 1 | 2022 | 8480 | 0.200 |
Why?
|
Pulse | 1 | 2021 | 228 | 0.200 |
Why?
|
Technology | 1 | 2023 | 302 | 0.190 |
Why?
|
Heart | 3 | 2023 | 4460 | 0.190 |
Why?
|
Physical Fitness | 2 | 2022 | 732 | 0.180 |
Why?
|
Female | 23 | 2023 | 380020 | 0.180 |
Why?
|
Physical Endurance | 1 | 2022 | 370 | 0.180 |
Why?
|
Lung | 1 | 2018 | 9858 | 0.180 |
Why?
|
Soccer | 1 | 2021 | 133 | 0.170 |
Why?
|
Mediastinoscopy | 1 | 2018 | 31 | 0.170 |
Why?
|
Long QT Syndrome | 1 | 2023 | 453 | 0.170 |
Why?
|
Male | 22 | 2023 | 349776 | 0.170 |
Why?
|
CD4-CD8 Ratio | 1 | 2018 | 112 | 0.170 |
Why?
|
Stroke Volume | 3 | 2021 | 5002 | 0.160 |
Why?
|
Sports Medicine | 1 | 2020 | 225 | 0.150 |
Why?
|
Prevalence | 4 | 2022 | 15211 | 0.150 |
Why?
|
Incidence | 3 | 2023 | 20948 | 0.150 |
Why?
|
Mediastinum | 1 | 2018 | 267 | 0.150 |
Why?
|
Universities | 1 | 2022 | 951 | 0.140 |
Why?
|
Syncope | 1 | 2019 | 429 | 0.140 |
Why?
|
Cardiovascular Diseases | 3 | 2023 | 15142 | 0.140 |
Why?
|
Exercise Therapy | 1 | 2023 | 904 | 0.140 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2018 | 768 | 0.140 |
Why?
|
Predictive Value of Tests | 3 | 2022 | 15067 | 0.140 |
Why?
|
Blood Pressure | 2 | 2022 | 8551 | 0.140 |
Why?
|
Neoplasms | 2 | 2015 | 21675 | 0.130 |
Why?
|
Magnetic Resonance Imaging | 3 | 2021 | 35409 | 0.130 |
Why?
|
Adaptation, Physiological | 1 | 2021 | 1311 | 0.130 |
Why?
|
Prednisone | 1 | 2019 | 1574 | 0.120 |
Why?
|
Aged | 8 | 2023 | 163178 | 0.120 |
Why?
|
Retrospective Studies | 11 | 2023 | 77410 | 0.120 |
Why?
|
Adult | 13 | 2023 | 213889 | 0.120 |
Why?
|
Aquatic Organisms | 1 | 2014 | 46 | 0.120 |
Why?
|
Chest Pain | 1 | 2021 | 1114 | 0.120 |
Why?
|
Coronary Stenosis | 1 | 2020 | 833 | 0.120 |
Why?
|
Young Adult | 9 | 2023 | 56392 | 0.120 |
Why?
|
Arrhythmias, Cardiac | 2 | 2020 | 2267 | 0.110 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2021 | 980 | 0.110 |
Why?
|
Prospective Studies | 7 | 2023 | 53250 | 0.110 |
Why?
|
Bronchoscopy | 1 | 2018 | 861 | 0.110 |
Why?
|
Methotrexate | 1 | 2019 | 1726 | 0.110 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2015 | 629 | 0.100 |
Why?
|
Middle Aged | 10 | 2022 | 213241 | 0.100 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2014 | 729 | 0.100 |
Why?
|
Risk Factors | 4 | 2022 | 72252 | 0.090 |
Why?
|
Glucocorticoids | 1 | 2019 | 2107 | 0.090 |
Why?
|
Creatinine | 1 | 2015 | 1918 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1789 | 0.090 |
Why?
|
Follow-Up Studies | 5 | 2022 | 39001 | 0.080 |
Why?
|
Guidelines as Topic | 1 | 2015 | 1404 | 0.080 |
Why?
|
Coronary Angiography | 2 | 2020 | 4576 | 0.080 |
Why?
|
Hemodynamics | 1 | 2018 | 4197 | 0.080 |
Why?
|
Ventricular Function, Left | 1 | 2020 | 3660 | 0.070 |
Why?
|
Lymph Nodes | 1 | 2018 | 3476 | 0.070 |
Why?
|
American Heart Association | 2 | 2023 | 1057 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4152 | 0.070 |
Why?
|
Renal Dialysis | 1 | 2015 | 1783 | 0.070 |
Why?
|
Survival Analysis | 1 | 2019 | 10251 | 0.070 |
Why?
|
Positron-Emission Tomography | 2 | 2019 | 6237 | 0.060 |
Why?
|
Heart Transplantation | 1 | 2018 | 3113 | 0.060 |
Why?
|
Adolescent | 6 | 2023 | 85729 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 9944 | 0.060 |
Why?
|
United States | 5 | 2023 | 69859 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2020 | 19894 | 0.050 |
Why?
|
Cohort Studies | 2 | 2021 | 40545 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 25032 | 0.050 |
Why?
|
Respiratory Rate | 1 | 2022 | 162 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 7908 | 0.040 |
Why?
|
Troponin | 1 | 2022 | 524 | 0.040 |
Why?
|
Exercise Tolerance | 1 | 2022 | 768 | 0.040 |
Why?
|
Hospitals | 2 | 2021 | 3953 | 0.040 |
Why?
|
Pelvis | 1 | 2021 | 730 | 0.040 |
Why?
|
Troponin T | 1 | 2021 | 754 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2018 | 15281 | 0.030 |
Why?
|
Washington | 1 | 2015 | 314 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2019 | 57744 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2021 | 1225 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2019 | 2016 | 0.020 |
Why?
|
Defibrillators, Implantable | 1 | 2020 | 1439 | 0.020 |
Why?
|
Oxygen | 1 | 2022 | 4189 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2019 | 2647 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6487 | 0.020 |
Why?
|
Risk | 1 | 2021 | 9677 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2021 | 3817 | 0.020 |
Why?
|
Myocardium | 1 | 2021 | 4775 | 0.020 |
Why?
|
Societies, Medical | 1 | 2019 | 3740 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8337 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12786 | 0.020 |
Why?
|
Animals | 1 | 2015 | 168660 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8385 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10259 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 12788 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29052 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 23327 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 63042 | 0.010 |
Why?
|